Oral propranolol for retinopathy of prematurity: Risks, safety concerns, and perspectives

Journal of Pediatrics

Volumn 163, Issue 6, 2013, Pages

  Filippi, Luca ^a   Cavallaro, Giacomo ^b   Bagnoli, Paola ^c   Dal Monte, Massimo ^c   Fiorini, Patrizio ^a   Donzelli, Gianpaolo ^a   Tinelli, Francesca ^d   Araimo, Gabriella ^b   Cristofori, Gloria ^b   La Marca, Giancarlo ^a   Della Bona, Maria Luisa ^a   La Torre, Agostino ^e   Fortunato, Pina ^e   Furlanetto, Sandra ^f   Osnaghi, Silvia ^b   Mosca, Fabio ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d DEPARTMENT OF DEVELOPMENTAL NEUROSCIENCE   (Italy)

^e CAREGGI UNIVERSITY HOSPITAL   (Italy)

^f UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BEVACIZUMAB; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FENTANYL; KETAMINE; PROPRANOLOL; TERLIPRESSIN; VASCULOTROPIN;

ANESTHESIA INDUCTION; APNEA; ARTICLE; ATELECTASIS; BLOOD SAMPLING; BRADYCARDIA; CONTROLLED STUDY; DIODE LASER; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GENERAL ANESTHESIA; HEALTH CARE NEED; HEMODYNAMIC MONITORING; HUMAN; HYPOTENSION; KIDNEY METABOLISM; LASER COAGULATION; LIVER METABOLISM; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; METABOLIC BALANCE; NEWBORN; NEWBORN MORBIDITY; OPHTHALMOLOGY; PATIENT MONITORING; PEDIATRIC SURGERY; PILOT STUDY; PREMATURITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; RETINA DETACHMENT; RETROLENTAL FIBROPLASIA; RISK ASSESSMENT; RISK REDUCTION; SEPSIS; VITRECTOMY; WHEEZING;

EID: 84888315339     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2013.07.049     Document Type: Article

References (45)

1. C. Gilbert Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control Early Hum Dev 84 2008 77 82
2. W.V. Good, R.J. Hardy, V. Dobson, E.A. Palmer, D.L. Phelps, and M. Quintos The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study Pediatrics 116 2005 15 23
3. J.S. Penn, A. Madan, R.B. Caldwell, M. Bartoli, R.W. Caldwell, and M.E. Hartnett Vascular endothelial growth factor in eye disease Prog Retin Eye Res 27 2008 331 371
4. W.V. Good, R.J. Hardy, D.K. Wallace, D. Bremer, D.L. Rogers, and R.M. Siatkowski β-Blocking and racial variation in the severity of retinopathy of prematurity Arch Ophthalmol 130 2012 117 118
5. R.A. Saunders, M.L. Donahue, L.M. Christmann, A.V. Pakalnis, B. Tung, and R.J. Hardy Racial variation in retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group Arch Ophthalmol 115 1997 604 608
6. S.B. Liggett, S. Cresci, R.J. Kelly, F.M. Syed, S.J. Matkovich, and H.S. Hahn A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure Nat Med 14 2008 510 517
7. J.G. Baker The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors Br J Pharmacol 144 2005 317 322
8. C. Léauté-Labrèze, E. Dumas de la Roque, T. Hubiche, F. Boralevi, J.B. Thambo, and A. Taïeb Propranolol for severe hemangiomas of infancy N Engl J Med 358 2008 2649 2651
9. V. Praveen, R. Vidavalur, T.S. Rosenkrantz, and N. Hussain Infantile hemangiomas and retinopathy of prematurity: possible association Pediatrics 123 2009 e484 e489
10. L.E. Smith, E. Wesolowski, A. McLellan, S.K. Kostyk, R. D'Amato, and R. Sullivan Oxygen-induced retinopathy in the mouse Invest Ophthalmol Vis Sci 35 1994 101 111
11. J. Chen, and L.E. Smith Retinopathy of prematurity Angiogenesis 10 2007 133 140
12. C. Ristori, L. Filippi, M. Dal Monte, D. Martini, M. Cammalleri, and P. Fortunato Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade Invest Ophthalmol Vis Sci 52 2011 155 170
13. D. Martini, M.D. Monte, C. Ristori, E. Cupisti, S. Mei, and P. Fiorini Antiangiogenic effects of β2 -adrenergic receptor blockade in a mouse model of oxygen-induced retinopathy J Neurochem 119 2011 1317 1329
14. M. Dal Monte, L. Filippi, and P. Bagnoli Beta3-adrenergic receptors modulate vascular endothelial growth factor release in response to hypoxia through the nitric oxide pathway in mouse retinal explants Naunyn Schmiedebergs Arch Pharmacol 386 2013 269 278
15. M. Dal Monte, G. Casini, G. la Marca, B. Isacchi, L. Filippi, and P. Bagnoli Eye drop propranolol administration promotes the recovery of oxygen-induced retinopathy in mice Exp Eye Res 111C 2013 27 35
16. International Committee for the Classification of Retinopathy of Prematurity The International Classification of Retinopathy of Prematurity revisited Arch Ophthalmol 123 2005 991 999
17. Early Treatment For Retinopathy Of Prematurity Cooperative Group Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial Arch Ophthalmol 121 2003 1684 1694
18. Section on Ophthalmology American Academy of Pediatrics, American Academy of Ophthalmology, and American Association for Pediatric Ophthalmology and Strabismus Screening examination of premature infants for retinopathy of prematurity Pediatrics 117 2006 572 576
19. S. Jalali, D. Balakrishnan, Z. Zeynalova, T.R. Padhi, and P.K. Rani Serious adverse events and visual outcomes of rescue therapy using adjunct bevacizumab to laser and surgery for retinopathy of prematurity. The Indian Twin Cities Retinopathy of Prematurity Screening database Report number 5 Arch Dis Child Fetal Neonatal Ed 98 2013 F327 F333
20. P. Nuntnarumit, W. Yang, and H.S. Bada-Ellzey Blood pressure measurements in the newborn Clin Perinatol 26 1999 981 996
21. M.L. Della Bona, S. Malvagia, F. Villanelli, E. Giocaliere, D. Ombrone, and S. Funghini A rapid liquid chromatography tandem mass spectrometry-based method for measuring propranolol on dried blood spots J Pharm Biomed Anal 78-79 2013 34 38
22. L. Filippi, G. Cavallaro, P. Fiorini, S. Malvagia, M.L. Della Bona, and E. Giocaliere Propranolol concentrations after oral administration in term and preterm neonates J Matern Fetal Neonatal Med 26 2013 833 840
23. S.A. Glantz Primer of bostatistics 6th ed. 2005 McGraw-Hill New York
24. S.A. Glantz Statistical software program. Version 6.0 2005 McGraw-Hill New York
25. M. Dal Monte, D. Martini, V. Latina, B. Pavan, L. Filippi, and P. Bagnoli Beta-adrenoreceptor (β-AR) agonism influences retinal responses to hypoxia in a mouse model of retinopathy of prematurity Invest Ophthalmol Vis Sci 53 2012 2181 2192
26. J.A. Lavine, Y. Sang, S. Wang, M.S. Ip, and N. Sheibani Attenuation of choroidal neovascularization by β2-adrenoreceptor antagonism JAMA Ophthalmol 131 2013 376 382
27. C.K. Chan, L.N. Pham, J. Zhou, C. Spee, S.J. Ryan, and D.R. Hinton Differential expression of pro- and antiangiogenic factors in mouse strain-dependent hypoxia-induced retinal neovascularization Lab Invest 85 2005 721 733
28. C. Hoffmann, M.R. Leitz, S. Oberdorf-Maass, M.J. Lohse, and K.N. Klotz Comparative pharmacology of human beta-adrenergic receptor subtypes - characterization of stably transfected receptors in CHO cells Naunyn Schmiedebergs Arch Pharmacol 369 2004 151 159
29. J. Chen, J.S. Joyal, C.J. Hatton, A.M. Juan, D.T. Pei, and C.G. Hurst Propranolol inhibition of β-adrenergic receptor does not suppress pathologic neovascularization in oxygen-induced retinopathy Invest Ophthalmol Vis Sci 53 2012 2968 2977
30. L. Filippi, M.D. Monte, and P. Bagnoli Different efficacy of propranolol in mice with oxygen-induced retinopathy: could differential effects of propranolol be related to differences in mouse strains Invest Ophthalmol Vis Sci 53 2012 7421 7423
31. S. Raab, H. Beck, A. Gaumann, A. Yüce, H.P. Gerber, and K. Plate Impaired brain angiogenesis and neuronal apoptosis induced by conditional homozygous inactivation of vascular endothelial growth factor Thromb Haemost 91 2004 595 605
32. J.J. Haigh, P.I. Morelli, H. Gerhardt, K. Haigh, J. Tsien, and A. Damert Cortical and retinal defects caused by dosage-dependent reductions in VEGF-A paracrine signaling Dev Biol 262 2003 225 241
33. R.M. Sullivan, G. Stenwalt, F. Nasr, C. Lemon, and D.A. Wilson Association of an odor with activation of olfactory bulb noradrenergic beta-receptors or locus coeruleus stimulation is sufficient to produce learned approach responses to that odor in neonatal rats Behav Neurosci 114 2000 957 962
34. M.E. Gibbs, D.S. Hutchinson, and R.J. Summers Noradrenaline release in the locus coeruleus modulates memory formation and consolidation; roles for α- and β-adrenergic receptors Neuroscience 170 2010 1209 1222
35. R.M. Sullivan, D.A. Wilson, and M. Leon Norepinephrine and learning-induced plasticity in infant rat olfactory system J Neurosci 9 1989 3998 4006
36. H. Chim, B.S. Armijo, E. Miller, C. Gliniak, M.A. Serret, and A.K. Gosain Propranolol induces regression of hemangioma cells through HIF-1α- mediated inhibition of VEGF-A Ann Surg 256 2012 146 156
37. L. Filippi, G. Cavallaro, P. Fiorini, M. Daniotti, V. Benedetti, and G. Cristofori Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491 BMC Pediatr 10 2010 83
38. C. Pieh, H. Agostini, C. Buschbeck, M. Krüger, J. Schulte-Mönting, and U. Zirrgiebel VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity Br J Ophthalmol 92 2008 689 693
39. L. Filippi, E. Gozzini, M. Daniotti, F. Pagliai, S. Catarzi, and P. Fiorini Rescue treatment with terlipressin in different scenarios of refractory hypotension in newborns and infants Pediatr Crit Care Med 12 2011 e237 e241
40. J.M. Costello, and W.H. Franklin Preoperative and postoperative care of the infant with congenital heart disease M.G. MacDonald, M.M.K. Seshia, M.D. Mullett, Avery's neonatology pathophysiology & management of the newborn 6th ed. 2005 Lippincott Williams & Wilkins Philadelphia 738
41. D.H. Bourla, C.R. Gonzales, S. Valijan, F. Yu, C.W. Mango, and S.D. Schwartz Association of systemic risk factors with the progression of laser-treated retinopathy of prematurity to retinal detachment Retina 28 2008 S58 S64
42. B.G. Sood, A. Madan, S. Saha, D. Schendel, P. Thorsen, and K. Skogstrand Perinatal systemic inflammatory response syndrome and retinopathy of prematurity Pediatr Res 67 2010 394 400
43. SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network, W.A. Carlo, N.N. Finer, M.C. Walsh, W. Rich, M.G. Gantz, and A.R. Laptook Target ranges of oxygen saturation in extremely preterm infants N Engl J Med 362 2010 1959 1969
44. J.A. Montero, J.M. Ruiz-Moreno, E. Sanchis-Merino, and S. Perez-Martin Systemic beta-blockers may reduce the need for repeated intravitreal injections in patients with age-related macular degeneration treated by bevacizumab Retina 33 2013 508 512
45. C. Pieh, M. Krüger, W.A. Lagrèze, C. Gimpel, C. Buschbeck, and U. Zirrgiebel Plasma sE-selectin in premature infants: a possible surrogate marker of retinopathy of prematurity Invest Ophthalmol Vis Sci 51 2010 3709 3713